ArticleFrontiers in oncology2023

Postoperative ctDNA detection predicts relapse but has limited effects in guiding adjuvant therapy in resectable stage I NSCLC.

Bolin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.